Valerian extract, 20 mg 50 pcs.

Pharmacotherapeutic group

Sedative of herbal origin.

ATC code: N05CM09

Pharmacological action

The active ingredient is the ester of borneol and isovaleric acid. It has a moderately strong sedative effect, which is slow in onset but fairly stable. Facilitates the onset of natural sleep. In addition, the drug has antispasmodic effect on the smooth muscles of the gastrointestinal tract.

Indications

Increased nervous excitability, insomnia (difficulty falling asleep); as part of complex therapy – functional disorders of the cardiovascular system, spasms of the gastrointestinal tract.

Pharmacological effect

Pharmacotherapeutic group

Sedative of plant origin.

ATX code: N05CM09

Pharmacological action

The active principle of the drug is an ester of borneol and isovaleric acid. It has a moderate sedative effect, which occurs slowly, but is quite stable. Facilitates the onset of natural sleep. In addition, the drug has an antispasmodic effect on the smooth muscles of the gastrointestinal tract.

Special instructions

You should not take the drug for more than 1.5-2 months daily.

Impact on the ability to drive vehicles and machinery

During the treatment period, care must be taken when driving vehicles and machinery and when engaging in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.

Active ingredient

Valerian officinalis rhizomes with roots

Composition

Composition per tablet

Valerian extract thick – 20.00 mg

Excipients:

core: magnesium hydroxycarbonate (basic magnesium carbonate) – 50.50 mg, potato starch – 26.69 mg, gelatin – 0.23 mg, talc – 2.58 mg;

shell: VIVACOAT PM-2P-051 – 10.00 mg [hypromellose (hydroxypropyl methylcellulose) (E 464) – 5,000 mg, titanium dioxide – 1,280 mg, macrogol-3350 (polyethylene glycol-3350) – 0,500 mg, talc – 2,350 mg, hyprolose (hydroxypropylcellulose) – 0.500 mg, sunset yellow dye (E 110) – 0.013 mg, quinoline yellow dye (E 104) – 0.345 mg, iron oxide yellow dye (E 172) – 0.012 mg];

OPADRAY II 85F19250 transparent (OPADRY II 85F19250 Clear) – 1.00 mg [polyvinyl alcohol – 0.523 mg, macrogol (polyethylene glycol) – 0.147 mg, talc – 0.300 mg, polysorbate-80 (Tween-80) – 0.030 mg].

Pregnancy

The use of the drug is contraindicated in the first trimester of pregnancy. The use of the drug in the second and third trimester of pregnancy and during breastfeeding is possible if the expected benefit to the mother outweighs the potential risk to the fetus and child. You should consult your doctor.

Contraindications

Hypersensitivity to the components of the drug, sucrase-isomaltase deficiency, fructose intolerance, glucose-galactose malabsorption, children under 12 years of age.

With caution – chronic enterocolitis.

Side Effects

Possible lethargy, drowsiness, muscle weakness, depression, decreased performance (especially when used in high doses), and with prolonged use – constipation. In some cases, allergic reactions may develop.

Interaction

Strengthens the effect of sleeping pills and other drugs that depress the central nervous system, as well as antispasmodics.

Overdose

In case of an overdose, side effects such as lethargy, drowsiness, muscle weakness, depression, and decreased performance may increase. Treatment is symptomatic.

Storage conditions

At a temperature not higher than 25C. Keep out of the reach of children.

Shelf life

2 years.

Manufacturer

Pharmstandard-Leksredstva, Russia